Novel cyp51A mutation profile in Aspergillus fumigatus from a patient with systemic lupus erythematosus and limited systemic sclerosis: first clinical case of acquired azole-resistance in Colombia. [PDF]
Morales-Pertuz C +6 more
europepmc +1 more source
Genetic analysis of common triazole resistance mechanisms in a collection of <i>Aspergillus lentulus</i> clinical isolates from the United States. [PDF]
Martin-Vicente A +5 more
europepmc +1 more source
Synergistic effects of Cyp51 isozyme-specific azole antifungal agents on fungi with multiple <i>cyp51</i> isozyme genes. [PDF]
Ishii M +7 more
europepmc +1 more source
Azole-Resistant <i>Aspergillus fumigatus</i>: Epidemiology, Diagnosis, and Treatment Considerations. [PDF]
Zubovskaia A.
europepmc +1 more source
Laboratory Diagnostics of Aspergillosis: Present State and Future Directions. [PDF]
Tomazin R, Matos T.
europepmc +1 more source
Multicenter surveillance of antifungal susceptibility of clinical <i>Aspergillus</i> isolates to conventional and novel antifungal agents in Taiwan, 2021-2023. [PDF]
Hsieh M +4 more
europepmc +1 more source
Investigation of azole resistance in <i>Aspergillus</i> species isolated from clinical specimens by azole agar screening method. [PDF]
Yazgan Z +3 more
europepmc +1 more source
Clinical and Genomic Insights into Antifungal Resistance in <i>Aspergillus</i> Isolates from Thailand. [PDF]
Onchan T, Langsiri N, Thammahong A.
europepmc +1 more source
Sexual reproduction and the polygenic architecture of azole resistance in agricultural populations of <i>Aspergillus fumigatus</i>. [PDF]
Huang J, Liu H, He Y, Zhang Y.
europepmc +1 more source
The Silent Pandemic: Antifungal Resistance and the Future of Invasive Fungal Disease Management. [PDF]
Bagga R, Kavanoor Sridhar K.
europepmc +1 more source

